- Home
- CRNX vs CHX Comparison
CRNX vs CHX Comparison
Compare CRNX & CHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNX
- CHX
- Stock Information
- Founded
- CRNX 2008
- CHX 1882
- Country
- CRNX United States
- CHX United States
- Employees
- CRNX N/A
- CHX N/A
- Industry
- CRNX Biotechnology: Pharmaceutical Preparations
- CHX Industrial Machinery/Components
- Sector
- CRNX Health Care
- CHX Industrials
- Exchange
- CRNX Nasdaq
- CHX Nasdaq
- Market Cap
- CRNX 5.3B
- CHX 5.4B
- IPO Year
- CRNX 2018
- CHX N/A
- Fundamental
- Price
- CRNX $54.72
- CHX $30.64
- Analyst Decision
- CRNX Strong Buy
- CHX Buy
- Analyst Count
- CRNX 10
- CHX 4
- Target Price
- CRNX $73.70
- CHX $39.00
- AVG Volume (30 Days)
- CRNX 655.3K
- CHX 1.7M
- Earning Date
- CRNX 11-12-2024
- CHX 10-23-2024
- Dividend Yield
- CRNX N/A
- CHX 1.24%
- EPS Growth
- CRNX N/A
- CHX 7.15
- EPS
- CRNX N/A
- CHX 1.62
- Revenue
- CRNX $1,038,999.00
- CHX $3,665,501,000.00
- Revenue This Year
- CRNX N/A
- CHX N/A
- Revenue Next Year
- CRNX $494.25
- CHX $3.90
- P/E Ratio
- CRNX N/A
- CHX $18.92
- Revenue Growth
- CRNX N/A
- CHX N/A
- 52 Week Low
- CRNX $28.50
- CHX $25.46
- 52 Week High
- CRNX $62.53
- CHX $39.95
- Technical
- Relative Strength Index (RSI)
- CRNX 41.37
- CHX 52.77
- Support Level
- CRNX $58.21
- CHX $30.31
- Resistance Level
- CRNX $62.53
- CHX $32.08
- Average True Range (ATR)
- CRNX 2.48
- CHX 0.76
- MACD
- CRNX -0.33
- CHX 0.22
- Stochastic Oscillator
- CRNX 4.87
- CHX 66.20
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.
About CHX ChampionX Corporation
ChampionX provides chemical solutions and equipment for onshore and offshore oil and gas production. Its engineering expertise spans the well lifecycle, but the firm maintains a particular focus on the production phase. Key offerings include artificial lift services and drilling technologies, specializing in polycrystalline diamond cutter inserts. ChampionX was formed after Apergy acquired its chemical technologies business from Ecolab in 2020.